Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Rationale Ayahuasca is a South American psychoactive beverage that contains the naturally occurring psychedelic agent N,N-dimethyltryptamine (DMT). This "tea" has been used for centuries in religious and medicinal contexts in the rain forest areas of South America and is presently gaining the attention of psychedelic users in North America and Europe. Objectives In the present study, the psychological effects and tolerability of ayvahuasca were assessed. Methods Three increasing doses of encapsulated freeze-dried ayahuasca (0.5, 0.75, and 1.0 mg DMT/kg body weight) were administered to six healthy male volunteers with prior experience in the use of this tea, in a single-blind crossover placebo-controlled clinical trial. Results Ayahuasca produced significant dose-dependent increases in five of the six subscales of the Hallucinogen Rating Scale, in the LSD, MBG, and A scales of the Addiction Research Center Inventory, and in the "liking", "good effects" and "high" visual analogue scales. Psychological effects were first noted after 30-60 min, peaked between 60-120 min, and were resolved by 240 min. The tea was well tolerated from a cardiovascular point of view, with a trend toward increase for systolic blood pressure. Modified physical sensations and nausea were the most frequently reported somatic-dysphoric effects. The overall experience was regarded as pleasant and satisfactory by five of the six volunteers, while one volunteer experienced an intensely dysphoric reaction wi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ayahuasca has been demonstrated to be safe in naturalistic (35, 108) and clinical settings, across varying dosages and multiple administrations (26, 109–112).”
From Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol (2025) · cites this paper as [109]
In the citing paper
“Ayahuasca was found to significantly raise the systolic and diastolic blood pressure by 35 Hgmm and the pulse rate by 26 bpm in a 2 min time interval while the rate of increase declines upon repeated intake (Riba et al., 2001).”
From The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization (2016) · cites this paper as Riba et al., 2001
Citations
Cites
(1970) · Cited by 24,983
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · cited 1×
“…and cognitive modifications induced by these agents, as in another study psilocybin's subjective effects were found to be increased rather than reverted by the D 2 receptor antagonist, haloperidol , while they were effectively counteracted by ketanserin and risperidone (Vollenweider et al. 1998).”
BackgroundLane, R. D., Reiman, E. M., Axelrod, B., Yun, L.-S., Holmes, A., & Schwartz, G. E. (1998) · Journal of Cognitive Neuroscience · doi:10.1162/089892998562924 · Cited by 671 · cited 2×
“A recent PET study has implicated the ACC in normal emotional awareness (Lane et al. 1998), and psilocybin administration leads to increases in metabolism in this area, where 5-HT 2A -mediated EPSPs/EPSCs have also been recorded (Aghajanian and Marek 1997).”
BackgroundEvidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
Glennon, R. A., Titeler, M., & McKenney, J. D. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90436-3 · Cited by 631
AGHAJANIAN, G. K., & MAREK, G. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00051-8 · Cited by 514
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453
Vollenweider, F. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00246-1 · Cited by 444 · cited 1×
“…revealed patterns of increased metabolism throughout the brain, and more specifically in the prefrontal cortices, particularly in the right hemisphere, in healthy volunteers after dosing with psilocybin (Vollenweider et al. 1997; Gouzoulis- Mayfrank et al. 1999b) and mescaline (Hermle et al. 1992).”
BackgroundSerotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors
Pazos, A., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90326-5 · Cited by 436
McKenna, D. J., Towers, G. H. N., & Abbott, F. (1984) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(84)90003-5 · Cited by 398 · cited 8×
“When compared with IV DMT, it is reasonable to assume that the reversible MAO-inhibiting properties of harmine and harmaline leads to a transient increase in endogenous monoamines, in addition to DMT's own cardiovascular effects.”
BackgroundMethodResultInfluentialHuman psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.
GROB, C. S., McKENNA, D. J., CALLAWAY, J. C., BRITO, G. S., NEVES, E. S., OBERLAENDER, G., SAIDE, O. L., LABIGALINI, E., TACLA, C., MIRANDA, C. T., et al. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199602000-00004 · Cited by 338
Self-citation
Cited by
Items 201–300 of 321
Zkušenost s halucinogenní rostlinou ayahuasca v kontextu šamanského rituálu
Kavenská, V., & Šimonová, H. (2014) · Anthropologia integra · doi:10.5817/ai2014-1-51 · Cited by 11
SANTOS, R. G. D., Osório, F. D. L., Crippa, J. A. S., & Hallak, J. E. C. (2017) · Journal of Psychedelic Studies · doi:10.1556/2054.01.2017.004 · Cited by 10
Brandt, S. D., Martins, C. P. B., Freeman, S., Dempster, N. M., WAINWRIGHT, M. S., Riby, P. G., & Alder, J. F. (2007) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2007.12.024 · Cited by 9
Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review
Viljoen, G., & Betzler, F. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_534 · Cited by 9
Daldegan‐Bueno, D., Favaro, V. M., Tófoli, L. F., Sussulini, A., Cassas, F., & Oliveira, M. G. M. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2021.1971342 · Cited by 8
Takiwasi: addiction treatment in the "Singing House"
O’Shaughnessy, D. M. (2017) · ResearchOnline at James Cook University (James Cook University) · doi:10.4225/28/5a9dce00eafa6 · Cited by 19
Increases in Aesthetic Experience Following Ayahuasca Use: A Prospective, Naturalistic Study
Aday, J. S., Bloesch, E. K., Davis, A. K., Domoff, S. E., Scherr, K. C., Woolley, J. D., & Davoli, C. C. (2024) · Journal of Humanistic Psychology · doi:10.1177/00221678241230609 · Cited by 9
The Hallucinogen Rating Scale: Updated Factor Structure in a Large, Multistudy Sample
Calder, A. E., Qualls, C., Hasler, G., Elmiger, D., & Strassman, R. J. (2024) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2024.100436 · Cited by 10
Apud, I., Scuro, J., Carrera, I., & Oliveri, A. (2022) · Journal of Psychedelic Studies · doi:10.1556/2054.2022.00202 · Cited by 7
Labate, B. C., & Feeney, K. (2011) · Periferia · doi:10.12957/periferia.2011.4054 · Cited by 7
CHARLATANS, SEEKERS, AND SHAMANS: THE AYAHUASCA BOOM IN WESTERN PERUVIAN AMAZONIA
Homan, J. (2011) · KU ScholarWorks (The University of Kansas) · Cited by 21
Sabucedo, P., Andión, O., Neimeyer, R. A., Soto-Angona, O., Javkin, J., Haro, J. M., Farré, M., & González, D. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1484736 · Cited by 6
Altered States of Consciousness: Drug- Induced States
Pace-Schott, E. F., & Hobson, J. A. (2007) · Blackwell Publishing Ltd eBooks · doi:10.1002/9780470751466.ch11 · Cited by 7
Al-Imam, A., Motyka, M. A., Hoffmann, B., Magowska, A. M., & Michalak, M. (2023) · Pharmaceuticals · doi:10.3390/ph16060831 · Cited by 7
Horák, M. (2017) · Mendelova univerzita v Brně eBooks · doi:10.11118/978-80-7509-510-7 · Cited by 6
L’Ayahuasca : clinique, neurobiologie et ambiguïté thérapeutique
Laqueille, X., & Martins, S. (2007) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2006.09.015 · Cited by 10
That deep internal voice: Controlled administration of Salvia divinorum
Addy, P. H. (n.d.) · ProQuest Demo Repository · Cited by 6
Apud, I., Scuro, J., Rodríguez, L. C., Dossi, G. H., Carrera, I., Lozano, F., & Retta, J. I. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2261017 · Cited by 5
Guidelines for Establishing Safety in Ayahuasca and Ibogaine Administration in Clinical Settings
Rocha, J. M., Reis, J. A. S., Rossi, G. N., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2023) · Psychoactives · doi:10.3390/psychoactives2040024 · Cited by 6
Greene, S. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818788-3.00014-0 · Cited by 5
Aspectos Farmacológicos e Toxicológicos do Alcaloide N, N – Dimetiltriptamina (DMT)
Machado, L. C., Cruz, R. H. D., Higa, S. S., Silva, T. R. B., Lima, T. C., & Seriani, R. (2020) · Brazilian Journal of Natural Sciences · doi:10.31415/bjns.v3i1.84 · Cited by 7
Bonson, K. R. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0000166.pub2 · Cited by 6
Soto-Angona, Ó., Andión, Ó., Sabucedo, P., Neimeyer, R. A., Haro, J. M., Javkin, J., Farré, M., & González, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-13251-5 · Cited by 5
Motyka, M. A. (2022) · UR Journal of Humanities and Social Sciences · doi:10.15584/johass.2022.3.1 · Cited by 4
Bonomo, Y. A., Norman, A. F., Collins, L., Ross, M., Dwyer, J. L., Perkins, D., & Sarris, J. J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1545915 · Cited by 4
de Moura, A. M., Aragão, M. B. D. M., Conceição, D. C. D. O., & Seixas, K. B. (2022) · Research Society and Development · doi:10.33448/rsd-v11i4.27182 · Cited by 5
Matoc, M. S., Stiperski, Z., & Hruška, T. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1003821 · Cited by 4
Kavenská, V. (2014) · Folia Universitatis Agriculturae et Silviculturae Mendelianae Brunensis · doi:10.11118/978-80-7509-881-8-0048 · Cited by 4
Clinical pharmacology of ayahuasca: potential applications and future considerations
Guerra, L. T. L., Dias, I. C. D. S., Hallak, J. E. C., & SANTOS, R. G. D. (2025) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2025.2577726 · Cited by 3
Oña, G. (2023) · Quaderns de l'Institut Català d'Antropologia · doi:10.56247/qua.401 · Cited by 4
Lima, G., Soares, C., Teixeira, M., & Castelo-Branco, M. S. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16264 · Cited by 3
The Novelty of Ayahuasca Scale and the prediction of intentions to use
Altman, B. R., Mian, M. N., & Earleywine, M. (2020) · Journal of Psychedelic Studies · doi:10.1556/2054.2020.00117 · Cited by 3
Acute and Long-Term Effects of Ayahuasca on (Higher-Order) Cognitive Processes
Mason, N. L., & Kuypers, K. P. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_7 · Cited by 4
Self-perception and self-recognition while looking in the mirror on psilocybin
Elias, S., Spivak, S., Alverez, A., Olivares, A. G., Ferrol, M., & Keenan, J. P. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00251 · Cited by 3
Ayahuasca-Tourismus in Südamerika
Wolff, T. J. (2018) · Springer eBooks · doi:10.1007/978-3-658-22138-6_38 · Cited by 5
The role of ceremonial ayahuasca use and the healing of eating disorders: a qualitative study
Renelli, M. (2018) · Lu Zone Ul (Laurentian University) · Cited by 10
Update of the Altered States Database (ASDB): 2022-12-31Preprint
Peters, M., Prugger, J., Dimkov, P. R., & Schmidt, T. T. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/wdfhg · Cited by 3
Andión, Ó., Bouso, J. C., Sarris, J. J., Tófoli, L. F., Opaleye, E. S., & Perkins, D. (2025) · PLOS mental health. · doi:10.1371/journal.pmen.0000097 · Cited by 3
Aicher, H., Wicki, I. A., Meling, D., Mueller, M. J., Dornbierer, D., & Scheidegger, M. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251344689 · Cited by 3
Psychedelics and the Serotonin Hypothesis of Eating Disorders
Bilenker, D., & Avena, N. M. (2025) · Brain Sciences · doi:10.3390/brainsci15080893 · Cited by 2
Psychedelic-assisted grief therapy: a mixed-method case study
Sabucedo, P., Evans, C., Nicolson, D., Farré, M., & González, D. (2024) · Mortality · doi:10.1080/13576275.2024.2434456 · Cited by 2
Estrella-Parra, E. A., Ávila-Acevedo, J. G., García‐Bores, A. M., Rivera-Cabrera, J. C., Alarcón-Villaseñor, E. F., Alejandre-García, I., & Alarcón-Aguilar, F. J. (2023) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2023.02.002 · Cited by 3
Unveiling ayahuasca psychopharmacology: the accomplishments of Jordi Riba (1968-2020)
SANTOS, R. G. D., de Araújo, D. B., Sanches, R. F., & Hallak, J. E. C. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0021 · Cited by 2
Increases in aesthetic experience following ayahuasca use: An open-label, naturalistic studyPreprint
Aday, J. S., Bloesch, E., Davis, A. K., Domoff, S. E., Scherr, K. C., Woolley, J. D., & Davoli, C. C. (2023) · doi:10.31234/osf.io/gd8h2 · Cited by 2
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01670-x · Cited by 1
Aniyar, D. C., Carrero, M., Hurtado, L., & Castro, A. (2022) · Dialnet (Universidad de la Rioja) · doi:10.5281/zenodo.6551144 · Cited by 1
Plant Poisons, Hallucinogens, and Traditional Medicines
Aronson, J. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-7959-7.00080-4 · Cited by 1
Lodetti, G., Réus, G. Z., & Rico, E. P. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.01.022 · Cited by 1
Soares, C., Lima, G., Teixeira, M., André, R., Rijo, P. M., Cabral, C., & Castelo-Branco, M. S. (2026) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsag004 · Cited by 1
Kessler, L. R., Dawud, L. M., Sterrett, J. D., Andersen, N. D., Elsayed, A. I., Gould, J., Pate, K. M., Campbell, W. K., Grigsby, J., Weiss, B., et al. (2026) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2026.100182 · Cited by 1
РЕНЕСАНС ПСИХОДЕЛІЧНОЇ ТЕРАПІЇ ТА ЇЇ ЗНАЧЕННЯ ДЛЯ УКРАЇНИ
Matrenitsky, V. L. (2022) · Likarska sprava · doi:10.31640/2706-8803-2022-(3-4)-04 · Cited by 3
Miller, N., Desnoyers-Stewart, J., Stepanova, E. R., Kitson, A., Bizzocchi, J., & Riecke, B. E. (2022) · Virtual Creativity · doi:10.1386/vcr_00059_1 · Cited by 3
dos Santos, B. C., Reis, A. K. G., Nucci, R. A. B., Campos, A. C. P., Martins, D. O., Daldegan‐Bueno, D., & Pagano, R. L. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100087 · Cited by 1
Greene, S. L. (2025) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2024.12.002 · Cited by 1
Enteógenos e Inteligência Existencial: Plantas Mestres como Instrumentos Cognitivos
Tupper, K. W. (2011) · Periferia · doi:10.12957/periferia.2011.3946 · Cited by 7
Santos, A. C., Azevedo, B. R. D. M. S., Pereira, N. K., Irulegui, R. D. S. C., & Baracho, N. C. D. V. (1970) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcsfmit.v3i4.172 · Cited by 1
Neuropsychological effect on long-term Ayahuasca use
Tucker, T. D. (2018) · Digital Archive @ GSU · doi:10.57709/12628841 · Cited by 1
Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50012-x · Cited by 1
Ayahuasca: farmacología, efectos agudos, potencial terapéutico y rituales
Aliño, M., Gadea, M., Miguel, J. P. S., & Espert, R. (2015) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia) · Cited by 3
Triptamina e dimetiltriptamina em melanomas: biossíntese, metabolização e atividades antitumorais
Coimbra, J. B. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2012.tde-07032013-095711 · Cited by 2
Saiz, B., & Carlos, J. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 11
McIlhenny, E. H. (2012) · Louisiana State University · doi:10.31390/gradschool_dissertations.2049 · Cited by 3
Estudos de farmacocinética dos alcalóides da ayahuasca
Pires, A. P. S. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2011.tde-21012011-162520 · Cited by 3
Zamarrenho, L. G. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.59.2014.tde-17102014-103415
Het gebruik van overige Tripmiddelen
Vervaeke, H. (2008) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6554-8_13
Monoamine Oxidase and Sensory Gating: Psychophysiological Vulnerabilities among Teenage Smokers
Wan, L. (2006) · VTechWorks (Virginia Tech) · Cited by 1
Palhano-Fontes, F. (2012) · Americanae (AECID Library) · Cited by 5
Brust, J. C. M. (2007) · Elsevier eBooks · doi:10.1016/b978-2-84299-712-0.50008-5
Tavares, L. S. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2014.tde-30102014-162441 · Cited by 2
LAS PROPIEDADES FARMACOCINÉTICAS DEL AYAHUASCA THE PHARMACOLOGICAL PROPERTIES OF AYAHUASCA
Cornejo, E., & Cornejo, G. S. E. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 7
The Relaxation System Theoretical Construct
Wisneski, L. (2017) · Routledge eBooks · doi:10.1201/9781315153889-5
Geschichte der Psychedelika in der Medizin
Sessa, B. (2017) · Springer eBooks · doi:10.1007/978-3-642-55125-3_99 · Cited by 1
Melo, W. (2014) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2014.11.d.17573 · Cited by 2
Efeitos agudos e subagudos de dose única de Ayahuasca no reconhecimento de expressões faciais
Rocha, J. M. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2020.tde-13042020-155227 · Cited by 1
The Relaxation System: Theoretical Construct
(2009) · CRC Press eBooks · doi:10.1201/b10166-5
Ayahuasca as a Versatile Therapeutic Agent: From Molecules to Metacognition and Back
Valle, M., Domínguez‐Clavé, E., Elices, M., Pascual, J. C., Soler, J., Morales-Garcia, J. A., Pérez‐Castillo, A., & Riba, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_1 · Cited by 1
Self-citationRossi, G. N. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2020.tde-08022021-150020
Fonseca, A. M. (2021) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Proceedings 榊原カンファレンス 今回の症例 : 心房細動 : 薬物療法の経過からカテーテルアブレーション実施に至るまで
梅村, 純. (2012) · CORE journal循環器 : current opinion & review for the next stage
(2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.358
Geschichte der Psychedelika in der Medizin
Sessa, B. (2017) · Springer eBooks · doi:10.1007/978-3-642-55214-4_99-1
(2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53266-4.50007-0
The ALSUntangled Group (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1337877 · Cited by 3
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00634-x
Hallucinogens and Related Drugs
(2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-25733-0_8
Silveira, G. D. O. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2020.tde-25082022-101857
New Complementary Approaches for the Treatment of Anxiety - A Narrative Review.
Santos, C. (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.8406100
Santos, F. P. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2023.tde-12122023-105953
Ramarushton, B. (2024) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc2332656
Ayahuasca-Tourismus in Südamerika
Wolff, T. J. (2024) · Springer eBooks · doi:10.1007/978-3-658-43431-1_47
Pérez, G. A. C., Iguarán, S., Murillo, L., & Espinosa-Duque, D. (2025) · Avances en Psicología Latinoamericana · doi:10.12804/revistas.urosario.edu.co/apl/a.13339
Cabral-Carvalho, R. M., Palhano-Fontes, F., de Araújo, D. B., & Sato, J. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.25.650509
Shah, R. J., & Sarangi, A. (2025) · Alcoholism Treatment Quarterly · doi:10.1080/07347324.2025.2500345
Ayahuasca's antidepressant effects covary with behavioral activation as well as mindfulness
Mian, M. N. (2019) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/1c38-bn99 · Cited by 1
Assessing novel expectancies about ayahuasca : a preliminary report
Altman, B. R. (2019) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/57py-y18d
Overall, J. S. (2025) · Applied Psychology Research · doi:10.59400/apr3074
Psychedelic agents for treatment-resistant depression
Gukasyan, N., & Griffiths, R. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00014-1
A percepção temporal no uso ritual da ayahuasca e rapé
Campagnoli, A. P. S. (2025) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2025.tde-17072025-151302
Metadata
- Authors
- Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J.
- Affiliations
- Hospital de Sant Pau (ES)
- University of Eastern Finland (FI)
- Venue
- Psychopharmacology
- Published
- 2001-02-22
- Volume
- 154
- Issue
- 1
- Pages
- 85-95
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2036881116
- Cited by
- 303
- References
- 31
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 15 · 2023: 22 · 2022: 35 · 2021: 24 · 2020: 20 · 2019: 12 · 2018: 13 · 2017: 18 · 2016: 14 · 2015: 15 · 2014: 8 · 2013: 8 · 2012: 15
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- ayahuasca, N,N-dimethyltryptamine, DMT, psychedelic effects, subjective experience, tolerability, dose-response relationship, Addiction Research Center Inventory, cardiovascular effects, nausea, healthy volunteers
- MeSH terms
- Adult, N,N-Dimethyltryptamine, Hallucinogens, Hemodynamics, Humans, Male, Plant Extracts, Plants, South America, Single-Blind Method
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.